Uta Ferrari

Uta Ferrari

Auto-generated profile, based on publicly available information

Uta Ferrari

Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
Sheikh Mohammed Shariful IslamSheikh Mohammed Shariful Islam
Sheikh Mohammed Shariful Islam
LNLouis Niessen
Louis Niessen
JSJochen Seissler
Jochen Seissler
UFUta Ferrari
Uta Ferrari
TBTuhin Biswas
Tuhin Biswas
ALAndreas Lechner
Andreas Lechner
To explore the association between knowledge on diabetes and glycemic control among patients with type 2 diabetes in Bangladesh. A cross-sectional study was conducted among 515 patients with type 2 diabetes attending a tertiary hospital in Dhaka, Bangladesh. Trained interviewers were used to collect data on socioeconomic status, time since the onset of diabetes, co-morbidities, anthropometric measurements, blood tests, knowledge and perceptions about the causes, management, and complications of diabetes through face to face interviewers based on a structured questionnaire. Diabetes knowledge was reported using a composite score. Chi square tests and correlation analysis were performed to measure the association between knowledge on diabetes and glycemic control. Overall, 45.6% participants had good, 37.7% moderate and 16.7% poor knowledge on diabetes. The mean composite score was 0.75 ± 0.28 and the proportion of participants with a score of ≤50% was 16.7%. Only 24.3% participants identified physical inactivity as a risk factor for diabetes. Knowledge on diabetes was significantly associated with education, gender, monthly income, duration of diabetes, body mass index, family history of diabetes, and marital status but not with glycated hemoglobin (HbA1c). Correlation matrix showed weak negative association between diabetes knowledge score and glycemic control (p < 0.001). Patients with type 2 diabetes in Bangladesh have limited knowledge on the causes, management and risk factors for diabetes, despite receiving professional health education and care in a tertiary diabetic hospital. Strategies to improve the quality of diabetes education and identifying other potential factors for glycemic control are important for ensuring optimum management of diabetes in Bangladesh.

1 June 2020 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
MDMichael Drey
Michael Drey
UFUta Ferrari
Uta Ferrari
MSMarina Schraml
Marina Schraml
WKWolfgang Kemmler
Wolfgang Kemmler
DSDaniel Schoene
Daniel Schoene
CSCornel Sieber
Cornel Sieber

8 February 2011 in International Journal of Biometeorology
Verified
Journal Article
Closed access
PDF file
UFUta Ferrari
Uta Ferrari
TETeresa Exner
Teresa Exner
EWEva R Wanka
Eva R Wanka
CBChristoph Bergemann
Christoph Bergemann
JMJulian Meyer-Arnek
Julian Meyer-Arnek
RFRainald Fischer
Rainald Fischer

26 November 2014 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
Sheikh Mohammed Shariful IslamSheikh Mohammed Shariful Islam
Sheikh Mohammed Shariful Islam
ALAndreas Lechner
Andreas Lechner
UFUta Ferrari
Uta Ferrari
GFGuenter Froeschl
Guenter Froeschl
DADewan Shamsul Alam
Dewan Shamsul Alam
LNLouis Niessen
Louis Niessen
Mobile phone technologies including SMS (short message service) have been used to improve the delivery of health services in many countries. However, data on the effects of mobile health technology on patient outcomes in resource-limited settings are limited. The aim of this study therefore is to measure the impact of a mobile phone SMS service on treatment success of newly diagnosed type 2 diabetes in an urban area of Bangladesh. This is a single-centred randomized controlled intervention trial (prospective) comparing standard-of-care with standard-of-care plus a mobile phone-based SMS intervention for 6 months. A total of 216 participants with newly diagnosed type 2 diabetes will be recruited. Data will be collected at the outpatient department of Bangladesh Institute of Health Science (BIHS) hospital at baseline and after 6 months. The primary outcome measure will be change in HbA1c between baseline and 6 months. The secondary outcome measures are self-reported medication adherence, clinic attendance, self-reported adoption of healthy behaviours, diabetes knowledge, quality of life and cost effectiveness of the SMS intervention. The inclusion criteria will be as follows: diagnosed as patients with type 2 diabetes by the BIHS physician, using oral medication therapy, living in Dhaka city, registered with the BIHS hospital, using a mobile phone, willing to return for follow up after 6 months and providing written informed consent. Participants will be allocated to control and intervention arms after recruitment using a randomization software. Data will be collected on socio-demographic and economic information, mobile phone use and habits, knowledge of prevention, management and complications of diabetes, self-perceived quality of life assessment, self-reported diseases, medical history, family history of diseases, medication history, medication adherence, health seeking behaviour, tobacco use, physical activity, diet, mental health status, life events and disability, anthropometric measurements of weight, height, blood pressure and blood tests for HbA1c. Mobile phone SMS services have the potential to communicate with diabetes patients and to build awareness about the disease, improve self-management and avoid complications also in resource-limited setting. If this intervention proves to be efficient and cost-effective in the current trial, large-scale implementation could be undertaken. DRKS00005188 .

4 April 2020 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
UFUta Ferrari
Uta Ferrari
CTCornelia Then
Cornelia Then
MRMarietta Rottenkolber
Marietta Rottenkolber
CSCanan Selte
Canan Selte
JSJochen Seissler
Jochen Seissler
BTBarbara Thorand
Barbara Thorand

30 December 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
UFUta Ferrari
Uta Ferrari
RSRalf Schmidmaier
Ralf Schmidmaier
TJTheresa Jung
Theresa Jung
MPMartin Reincke Prof
Martin Reincke Prof
SMSebastian Martini
Sebastian Martini
MDMichael Drey
Michael Drey
Context: Definition of etiological subgroups of sarcopenia may help to develop targeted treatments. insulin like growth factor-I (IGF-I), Insulinlike growth factor binding protein 3 (IGFBP3), and acid labile subunit (ALS) build a ternary complex that mediates growth hormone (GH) effects on peripheral organs, such as muscle. Low GH binding protein (GHBP) as a marker of GH receptor number would hint toward GH resistance. Objective: We aimed to analyze the association of IGF-I, IGFBP3, and ALS with sarcopenia. Study Participants and Setting: A total of 131 consecutively recruited patients of a geriatric ward were included in a single-center cross-sectional analysis; the nonsarcopenic patients served as controls. Methods: Measures included sarcopenia status by hand-grip strength measurement and Skeletal Muscle Index (SMI); IGF-I, IGFBP3, ALS, GH, GHBP; body mass index (BMI); Activity of Daily Living (ADL); Mini–Mental State Examination (MMSE); routine laboratory parameters; and statistical regression modeling. Results: Compared with controls, sarcopenic patients did not differ regarding age, sex, ADL, MMSE, C-reactive protein, glomerular filtration rate, and albumin serum concentrations. However, sarcopenic patients had significantly lower IGF-I, IGFBP3, and ALS. IGF-I and ALS associated significantly with sarcopenia and low hand-grip strength, even after adjustment for age, sex, BMI, and albumin, but not with low SMI. GHBP serum was low in sarcopenic patients, but normal in geriatric patients without sarcopenia. Over 60% of patients with IGF-I/ALS deficiency patients showed GH resistance. Conclusions: Our data suggest that in geriatric patients, low IGF-I/IGFBP3/ALS could be evaluated for causative connection of the sarcopenia spectrum. Low GHBP points toward potential GH resistance as one possible explanation of this deficiency.